JP2023548110A - 卵巣がんの検出及び治療方法 - Google Patents

卵巣がんの検出及び治療方法 Download PDF

Info

Publication number
JP2023548110A
JP2023548110A JP2023525978A JP2023525978A JP2023548110A JP 2023548110 A JP2023548110 A JP 2023548110A JP 2023525978 A JP2023525978 A JP 2023525978A JP 2023525978 A JP2023525978 A JP 2023525978A JP 2023548110 A JP2023548110 A JP 2023548110A
Authority
JP
Japan
Prior art keywords
ovarian cancer
subject
das
n3ap
diacspmd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023525978A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023548110A5 (enExample
Inventor
ファーマン ヨハネス
ハナシュ サミール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of JP2023548110A publication Critical patent/JP2023548110A/ja
Publication of JP2023548110A5 publication Critical patent/JP2023548110A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
JP2023525978A 2020-10-29 2021-10-27 卵巣がんの検出及び治療方法 Pending JP2023548110A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063107160P 2020-10-29 2020-10-29
US63/107,160 2020-10-29
PCT/US2021/056852 WO2022093960A1 (en) 2020-10-29 2021-10-27 Methods for the detection and treatment of ovarian cancer

Publications (2)

Publication Number Publication Date
JP2023548110A true JP2023548110A (ja) 2023-11-15
JP2023548110A5 JP2023548110A5 (enExample) 2024-10-28

Family

ID=81383153

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023525978A Pending JP2023548110A (ja) 2020-10-29 2021-10-27 卵巣がんの検出及び治療方法

Country Status (7)

Country Link
US (1) US20240044902A1 (enExample)
EP (1) EP4237090B1 (enExample)
JP (1) JP2023548110A (enExample)
KR (1) KR20230113742A (enExample)
CN (1) CN116490776A (enExample)
CA (1) CA3196725A1 (enExample)
WO (1) WO2022093960A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024020427A2 (en) * 2022-07-21 2024-01-25 Board Of Regents, The University Of Texas System Methods for the detection and treatment of ovarian cancer
KR20250017689A (ko) 2023-07-27 2025-02-04 가톨릭대학교 산학협력단 난소암 발병 위험률 예측 방법 및 분석장치

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007502983A (ja) * 2003-08-15 2007-02-15 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション がん検出のための多因子アッセイ
US20140221240A1 (en) * 2007-06-29 2014-08-07 Vermillion, Inc. Predictive markers for ovarian cancer
US20150276747A1 (en) * 2012-06-11 2015-10-01 Georgia Regents Research Institute, Inc. Biomarkers for ovarian cancer
US20180311224A1 (en) * 2016-06-29 2018-11-01 Tesaro, Inc. Methods of treating ovarian cancer
US20200025766A1 (en) * 2017-02-09 2020-01-23 Board Of Regents, The University Of Texas System Methods for the detection and treatment of lung cancer
JP2020118563A (ja) * 2019-01-24 2020-08-06 公立大学法人和歌山県立医科大学 卵巣腫瘍の評価用バイオマーカー

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1610127B1 (en) * 2003-03-11 2012-04-25 CRC Inc. N1,n12-diacetylspermine as tumor marker
MX2009000452A (es) * 2006-07-14 2011-11-07 Mannkind Corp Metodos para producir, mejorar y sostener respuestas inmunes contra epitopos restringidos mhc clase i para propositos profilacticos o terapeuticos.
US9733256B2 (en) * 2012-02-23 2017-08-15 Keio University Combined anticancer drug sensitivity-determining marker
GB201316347D0 (en) * 2013-09-13 2013-10-30 Cancer Rec Tech Ltd Biological fluid filtration assembly
US20160282351A1 (en) * 2013-10-28 2016-09-29 Salivatech Co., Ltd. Salivary biomarkers for cancers, methods and devices for assaying the same, and methods for determining salivary biomarkers for cancers
US10377783B2 (en) * 2015-06-12 2019-08-13 Brock University Methods and compounds for enhancing contrast in magnetic resonance imaging (MRI)
TW201800408A (zh) * 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑
WO2019178216A1 (en) * 2018-03-13 2019-09-19 Baylor Research Institute Methods and compositions for treating, diagnosing, and prognosing ovarian cancer
CN109870579B (zh) * 2019-02-03 2022-02-11 辽宁迈迪生物科技股份有限公司 单克隆抗体保护液及制备方法和应用、应用单克隆抗体保护液的试剂与免疫组化试剂盒

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007502983A (ja) * 2003-08-15 2007-02-15 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション がん検出のための多因子アッセイ
US20140221240A1 (en) * 2007-06-29 2014-08-07 Vermillion, Inc. Predictive markers for ovarian cancer
US20150276747A1 (en) * 2012-06-11 2015-10-01 Georgia Regents Research Institute, Inc. Biomarkers for ovarian cancer
US20180311224A1 (en) * 2016-06-29 2018-11-01 Tesaro, Inc. Methods of treating ovarian cancer
US20200025766A1 (en) * 2017-02-09 2020-01-23 Board Of Regents, The University Of Texas System Methods for the detection and treatment of lung cancer
JP2020118563A (ja) * 2019-01-24 2020-08-06 公立大学法人和歌山県立医科大学 卵巣腫瘍の評価用バイオマーカー

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NIEMI, RIIKKA JOHANNA, ET AL.: ":Urinary polyamines as biomarkers for ovarian cancer.", JOURNAL OF GYNECOLOGICAL CANCER, vol. 27.7, JPN7025004004, September 2017 (2017-09-01), pages 1360 - 1366, ISSN: 0005828793 *
VAN DEN BERG, GITA A., ET AL.: ":Determination of N-(3-acetamidopropyl) pyrrolidin-2-one, a metabolite of spermidine, in ur", JOURNAL OF CHROMATOGRAPHY B: BIOMEDICAL SCIENCES AND APPLICATIONS, vol. 383, JPN7025004005, 19 December 1986 (1986-12-19), pages 251 - 258, ISSN: 0005828794 *

Also Published As

Publication number Publication date
WO2022093960A1 (en) 2022-05-05
KR20230113742A (ko) 2023-08-01
EP4237090A1 (en) 2023-09-06
EP4237090A4 (en) 2024-09-25
EP4237090B1 (en) 2026-02-18
US20240044902A1 (en) 2024-02-08
CA3196725A1 (en) 2022-05-05
CN116490776A (zh) 2023-07-25

Similar Documents

Publication Publication Date Title
Manne et al. Keynote review: Recent advances in biomarkers for cancer diagnosis and treatment
EP2362942B1 (en) Biomarkers
CN108957006B (zh) 非酒精性脂肪肝疾病(nafld)和非酒精性脂肪性肝炎(nash)生物标记及其用途
US20240159753A1 (en) Methods for the detection and treatment of lung cancer
JP2020510816A (ja) 肺癌の検出および処置のための方法
JP2011515666A (ja) トリプルネガティブ乳がんに関連するｄｎａ修復タンパク質およびその使用法
MX2012014268A (es) Biomarcadores de cancer de pulmon y usos de los mismos.
JP2011523049A (ja) 頭頚部癌の同定、モニタリングおよび治療のためのバイオマーカー
US20180100858A1 (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
JP2013532830A (ja) 前立腺癌に関するバイオマーカー及びそれを使用する方法
CN108603887A (zh) 非酒精性脂肪肝疾病(nafld)和非酒精性脂肪性肝炎(nash)生物标记及其用途
AU2016214140A1 (en) Biomarkers for pancreatic cancer
US20240044902A1 (en) Methods for the detection and treatment of ovarian cancer
WO2024107923A1 (en) Methods for the detection and treatment of lung cancer
US20200087733A1 (en) Biomarker for measurement of response and prognosis of triple-negative breast cancer to anticancer agent
US20180274037A1 (en) Novel biomarkers for pancreatic diseases
WO2014153442A2 (en) Methods and systems for treatment of ovarian cancer
JP6755703B2 (ja) がんの検出法
CN111763736B (zh) 用于诊断甲状腺乳头状癌淋巴结转移的液体活检试剂盒
WO2024020427A2 (en) Methods for the detection and treatment of ovarian cancer
EP3295176A1 (en) Biomarkers for detection of tuberculosis risk
US20250116676A1 (en) Phosphopeptide/phosphoprotein signature predicting basal-like breast cancer recurrence
EP2607494A1 (en) Biomarkers for lung cancer risk assessment
KR20260043982A (ko) 폐 선암의 조직병리학적 아형 식별 및 예후 예측을 위한 바이오마커 및 이의 용도
HK40090190A (zh) 非酒精性脂肪肝疾病(nafld)和非酒精性脂肪性肝炎(nash)生物标记及其用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241018

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241018

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250813

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260331